DK1399482T3 - Bestemmelse af bone-sialoprotein i kropsvæsker til on-kologiske problemstillinger - Google Patents

Bestemmelse af bone-sialoprotein i kropsvæsker til on-kologiske problemstillinger

Info

Publication number
DK1399482T3
DK1399482T3 DK02758218T DK02758218T DK1399482T3 DK 1399482 T3 DK1399482 T3 DK 1399482T3 DK 02758218 T DK02758218 T DK 02758218T DK 02758218 T DK02758218 T DK 02758218T DK 1399482 T3 DK1399482 T3 DK 1399482T3
Authority
DK
Denmark
Prior art keywords
bone sialoprotein
antibodies
oncological
issues
determination
Prior art date
Application number
DK02758218T
Other languages
English (en)
Inventor
Franz Paul Armbruster
Markus Karmatschek
Mats Paulsson
Original Assignee
Immundiagnostik Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immundiagnostik Ag filed Critical Immundiagnostik Ag
Application granted granted Critical
Publication of DK1399482T3 publication Critical patent/DK1399482T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Ceramic Products (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK02758218T 2001-06-13 2002-06-06 Bestemmelse af bone-sialoprotein i kropsvæsker til on-kologiske problemstillinger DK1399482T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01114388 2001-06-13
PCT/EP2002/006219 WO2002100901A2 (de) 2001-06-13 2002-06-06 Bestimmung von bone-sialoprotein in körperflüssigkeiten für onkologische fragestellungen

Publications (1)

Publication Number Publication Date
DK1399482T3 true DK1399482T3 (da) 2009-07-20

Family

ID=8177717

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02758218T DK1399482T3 (da) 2001-06-13 2002-06-06 Bestemmelse af bone-sialoprotein i kropsvæsker til on-kologiske problemstillinger

Country Status (7)

Country Link
US (1) US7790853B2 (da)
EP (1) EP1399482B1 (da)
JP (1) JP4438987B2 (da)
AT (1) ATE425991T1 (da)
DE (1) DE50213368D1 (da)
DK (1) DK1399482T3 (da)
WO (1) WO2002100901A2 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8282943B2 (en) 2005-05-31 2012-10-09 Ralf Jochem Therapeutic composition for use in the prevention and treatment of bone metastases
EP3182995B1 (en) * 2014-08-19 2019-11-27 Immundiagnostik AG Medicament and apparatus for treating chronic kidney disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340934A (en) * 1989-11-03 1994-08-23 The United States Of Americas As Represented By The Secretary Of Health & Human Services CDNA sequences of human bone matrix proteins
EP1400536A1 (en) * 1991-06-14 2004-03-24 Genentech Inc. Method for making humanized antibodies
AU3035699A (en) * 1998-03-27 1999-10-18 Seibel, Markus Determination of the probability of bone metastases in patients with primary carcinomas
AU769773B2 (en) * 1998-12-22 2004-02-05 University Of Virginia Patent Foundation Bone sialoprotein based toxic gene therapy for the treatment of calcified tumors and tissues
AU769185B2 (en) * 1999-04-09 2004-01-15 Government of The United States of America, as represented by The Secretary Department of Health & Human Services, The National Institutes of Health, The Complex formed by N-linked glycoproteins (siblings) and factor H

Also Published As

Publication number Publication date
DE50213368D1 (de) 2009-04-30
EP1399482B1 (de) 2009-03-18
JP4438987B2 (ja) 2010-03-24
US20050054016A1 (en) 2005-03-10
US7790853B2 (en) 2010-09-07
JP2005508870A (ja) 2005-04-07
WO2002100901A3 (de) 2003-09-18
EP1399482A2 (de) 2004-03-24
WO2002100901A2 (de) 2002-12-19
ATE425991T1 (de) 2009-04-15

Similar Documents

Publication Publication Date Title
DE69433663D1 (de) Antikörper gegen menschliches prostatspezifisches drüsenkallikrein
BR0213565A (pt) Anticorpo de anti-tnf alfa modificado
EP2277917A3 (en) B7-H3L cell surface target and a family of antibodies recognizing that target
DK1368060T3 (da) HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
TR200200472T2 (tr) Anti-Erb B2 antikorları ile tedavi için dozajlar
PL378333A1 (pl) Sposoby profilaktyki i leczenia choroby Alzheimera (AD)
BR0208603A (pt) Marcadores de tumor para carcinoma de células renais
EP1467757A4 (en) USE OF ANTIBODIES TO THE MUC18 ANTIGEN
ATE517922T1 (de) Stabilisierte einzel-domänen-antikörper in einer pharmazeutischen zusammensetzung ausgestaltet für inhalation
AT500379B1 (de) Tau-proteine
IL195338A (en) An antibody comprising an FC variant containing amino acid replaces d or e at position 239, a medicament containing it and its use
BRPI0418766A (pt) anticorpos e moléculas derivadas destes que se ligam às proteìnas steap-1
DK1349870T3 (da) Sammensætninger til terapien og diagnosen af ovariecancer
SI1572087T1 (sl) Protitelesa proti antigenu tmeff2 raka in njihovauporaba
TR200001646T2 (tr) Bir salgılanmış meme kanseri proteini olan mamaglobin.
DK1399482T3 (da) Bestemmelse af bone-sialoprotein i kropsvæsker til on-kologiske problemstillinger
GB0004576D0 (en) Proteins
TR200102655T2 (tr) Dört L. infantum proteininin antijen belirleyicilerini kodlayan kimerik gen.
CY1109904T1 (el) Προαγωγεας της il-18bp, η παρασκευη και χρηση του
ATE366937T1 (de) Krebs-assoziiertes protein
SG156619A1 (en) Novel cancer associated antibodies and antigens and their use in cancer diagnosis
ATE466076T1 (de) Gewebe transglutaminase
DE69931054D1 (de) Monoklonale antikörper gegen s100
ATE527354T1 (de) Diabetogene epitope